Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets
Atish Prakash, Jaspreet Kalra, Vasudevan Mani, et al.
Expert Review of Neurotherapeutics (2014) Vol. 15, Iss. 1, pp. 53-71
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Social brain, social dysfunction and social withdrawal
Stefano Porcelli, Nic J.A. van der Wee, Steven van der Werff, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 97, pp. 10-33
Open Access | Times Cited: 319
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Zhenqi Yang, Yong Zou, Lifeng Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3841-3841
Open Access | Times Cited: 49
Ginsenosides attenuate d-galactose- and AlCl3-inducedspatial memory impairment by restoring the dysfunction of the neurotransmitter systems in the rat model of Alzheimer's disease
Yan Zhang, Zifeng Pi, Fengrui Song, et al.
Journal of Ethnopharmacology (2016) Vol. 194, pp. 188-195
Closed Access | Times Cited: 71
Ginsenoside Rg3 Prevents Cognitive Impairment by Improving Mitochondrial Dysfunction in the Rat Model of Alzheimer’s Disease
Yan Zhang, Xiaomei Yang, Shuang Wang, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 36, pp. 10048-10058
Closed Access | Times Cited: 55
Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease
Ahmed Faraz Khan, Quadri Adewale, Tobias R. Baumeister, et al.
Brain (2021) Vol. 145, Iss. 5, pp. 1785-1804
Open Access | Times Cited: 43
The underlying roles and neurobiological mechanisms of music-based intervention in Alzheimer's disease: A comprehensive review
Liyang Sun, Qin Wang, Jing Ai
Ageing Research Reviews (2024) Vol. 96, pp. 102265-102265
Closed Access | Times Cited: 6
Barbaloin’s Chemical Intervention in Aluminum Chloride Induced Cognitive Deficits and Changes in Rats through Modulation of Oxidative Stress, Cytokines, and BDNF Expression
Imran Kazmi, Muhammad Afzal, Faisal Imam, et al.
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6976-6985
Open Access | Times Cited: 5
Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain
Binbin Wei, Mingyan Liu, Zaixing Chen, et al.
Acta Pharmacologica Sinica (2018) Vol. 39, Iss. 4, pp. 616-625
Open Access | Times Cited: 32
Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review)
Mubashir Hassan, Qamar Abbas, Sung‐Yum Seo, et al.
Molecular Medicine Reports (2018)
Open Access | Times Cited: 24
The cognitive dysfunction of claustrum on Alzheimer’s disease: A mini-review
Chunyan Chen, Guang-Yi Yang, Hai-Xia Tu, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 7
Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat
Xiaowen Han, Mengjun Min, Juan Wang, et al.
Journal of Neuroscience Research (2017) Vol. 96, Iss. 1, pp. 138-150
Closed Access | Times Cited: 23
Aluminium chloride-induced hippocampal damage: CA3 hippocampal subfield involvement and the neuroprotective role of Buchholzia coriacea ethanolic seed extract
Stephen Taiye Adelodun, Oluwadamilola Adunni Ishola, Ayodeji Zabdiel Abijo, et al.
Phytomedicine Plus (2021) Vol. 1, Iss. 4, pp. 100104-100104
Open Access | Times Cited: 15
Ameliorative effect of myrcene in mouse model of Alzheimer's disease
Rakesh Kumar, Rajan Kumar, Neha Sharma, et al.
European Journal of Pharmacology (2021) Vol. 911, pp. 174529-174529
Closed Access | Times Cited: 15
Effects of novel acylhydrazones derived from 4-quinolone on the acetylcholinesterase activity and Aβ42 peptide fibrils formation
Gisele da Silva, Micheli Figueiró, Cláudio F. Tormena, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2016) Vol. 31, Iss. 6, pp. 1464-1470
Open Access | Times Cited: 15
Quantitative-profiling of neurotransmitter abnormalities in the disease progression of experimental diabetic encephalopathy rat
Xueyan Zhou, Qiuxiang Zhu, Xiaowen Han, et al.
Canadian Journal of Physiology and Pharmacology (2015) Vol. 93, Iss. 11, pp. 1007-1013
Open Access | Times Cited: 14
An integrated strategy using LC-MS/MS combined with in vivo microdialysis for the simultaneous determination of lignans of Schisandra chinensis (Turcz.) Baill. Fructus and endogenous neurotransmitters: application in pharmacokinetic and pharmacodynamic studies
Jun Fu, Hongxu Zhang, Shu Liu, et al.
Food & Function (2021) Vol. 12, Iss. 19, pp. 8932-8945
Closed Access | Times Cited: 11
Mahanimbine Improved Aging-Related Memory Deficits in Mice through Enhanced Cholinergic Transmission and Suppressed Oxidative Stress, Amyloid Levels, and Neuroinflammation
Vasudevan Mani, Nur Syamimi Mohd Azahan, Kalavathy Ramasamy, et al.
Brain Sciences (2021) Vol. 12, Iss. 1, pp. 12-12
Open Access | Times Cited: 11
SERS technology and advances in neurosurgery
Hulin Zhao, Wenwen Li, Jing Li, et al.
Applied Spectroscopy Reviews (2023) Vol. 59, Iss. 2, pp. 224-246
Closed Access | Times Cited: 4
Antidepressant Role in Modulating Neurotransmitter Imbalance to Improve Cognitive Impairment in Patient with Alzheimer’s Disease
Jamil Nasrallah
(2024), pp. 1-7
Open Access | Times Cited: 1
UHPLC-MS/MS combined with microdialysis for simultaneous determination of nicotine and neurotransmitter metabolites in the rat hippocampal brain region: application to pharmacokinetic and pharmacodynamic study
Mingyu Zhu, Lili Cui, Guanglin Liu, et al.
Analytical Methods (2024) Vol. 16, Iss. 24, pp. 3815-3830
Closed Access | Times Cited: 1
Alzheimer’s disease: current and future therapy
Diane Stephenson
Expert Review of Neurotherapeutics (2015) Vol. 15, Iss. 1, pp. 1-2
Closed Access | Times Cited: 9
Influence of PICALM and CLU risk variants on beta EEG activity in Alzheimer’s disease patients
Aarón Maturana-Candelas, Carlos Gómez, Jesús Poza, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Study on multi-target effects of the novel HDAC6 inhibitor W5 on Aβ/Cu2+-induced Alzheimer's disease model of rats
Ruihua Liu, Linli Guo, Yanan Zhao, et al.
Brain Research (2024) Vol. 1832, pp. 148847-148847
Closed Access
Unveiling Nature’s Arsenal: Natural Sources for Drug Discovery in Alzheimer’s Disease
Chandran Remya, N. Aiswarya, K.V. Dileep
(2024), pp. 333-366
Closed Access
DISRUPTED SYNTHESIS OF NEUROTRANSMITTERS IN THE PATHOPHYSIOLOGY OF DIABETIC ENCEPHALOPATHY (LITERATURE REVIEW)
Yu. V. Bykov
Russian Biomedical Research (2024) Vol. 9, Iss. 2, pp. 57-63
Open Access
Page 1 - Next Page

Scroll to top